Aytu BioPharma Inc (AYTU)
3.09
+0.08
(+2.66%)
USD |
NASDAQ |
May 06, 16:00
Aytu BioPharma Debt to Equity Ratio: 0.4883 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.4883 |
September 30, 2023 | 0.5011 |
June 30, 2023 | 0.4157 |
March 31, 2023 | 0.6134 |
December 31, 2022 | 0.4813 |
September 30, 2022 | 0.4187 |
June 30, 2022 | 0.4105 |
March 31, 2022 | 0.2887 |
December 31, 2021 | 0.2244 |
September 30, 2021 | 0.19 |
June 30, 2021 | 0.1801 |
March 31, 2021 | 0.161 |
December 31, 2020 | 0.0067 |
September 30, 2020 | 0.0174 |
June 30, 2020 | 0.0103 |
March 31, 2020 | 0.0532 |
December 31, 2019 | 0.0154 |
September 30, 2019 | 0.00 |
Date | Value |
---|---|
June 30, 2019 | 0.00 |
March 31, 2019 | 0.3202 |
December 31, 2018 | 0.2531 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.0006 |
December 31, 2015 | 0.3225 |
September 30, 2015 | 0.3599 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
0.6134
Maximum
Mar 2023
0.2356
Average
0.19
Median
Sep 2021
Debt to Equity Ratio Benchmarks
Regen BioPharma Inc | -0.134 |
Clearday Inc | -0.5483 |
Bioxytran Inc | -- |
Shuttle Pharmaceuticals Holdings Inc | -- |
CEL-SCI Corp | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 131.25M |
Total Liabilities (Quarterly) | 98.40M |
Shareholders Equity (Quarterly) | 32.85M |
Current Ratio | 1.112 |
Net Debt Paydown Yield | 8.26% |